Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
European Molecular Biology Laboratory · Vrije Universiteit Brussel · +28 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,090
total citations
- FWCI
- 69.87
- Percentile
- 100%
- References
- 50
Citations per year
Authors
29- KFKristoffer ForslundCorresponding
European Molecular Biology Laboratory
- FHFalk Hildebrand
Vrije Universiteit Brussel, VIB-KU Leuven Center for Cancer Biology, VIB-VUB Center for Structural Biology, European Molecular Biology Laboratory
- TNTrine Nielsen
University of Copenhagen, Maersk (Denmark), Novo Nordisk Foundation, Novo Nordisk Foundation Center for Basic Metabolic Research
- GFGwen Falony
Rega Institute for Medical Research, VIB-KU Leuven Center for Cancer Biology, VIB-VUB Center for Structural Biology
- ELEmmanuelle Le Chatelier
Microbiologie de l’alimentation au service de la santé, Département Génétique Animale, Laboratoire d'Analyses Génétiques pour les Espèces Animales
Topics & keywords
Keywords
- Metformin
- Type 2 diabetes
- Gut flora
- Diabetes mellitus
- Computational biology
- Biology
- Medicine
- Bioinformatics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- IInnovationsfonden
- EMEuropean Molecular Biology Laboratory
- ECEuropean CommissionAwards: 600375, FP7/2007-2013, HEALTH-F4-2007-201052, 2007-2013, FP7/2007, 305312, 201052, 268985, HORIZON 2020, 261376
- ANAgence Nationale de la RechercheAward: ANR-11-DPBS-0001
- LLundbeckfonden
- NNNovo Nordisk
- GUGöteborgs Universitet
- CGCopenhagen Graduate School for Nanoscience and Nanotechnology
- NNNovo Nordisk Foundation Center for Basic Metabolic Research
- HLH. Lundbeck A/S